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Abstract
Background: Emergency Departments (EDs) are confronted with progressive overcrowding. As
a consequence, the workload for ED physicians increases and waiting times go up with the risk of
unnecessary complications and patient dissatisfaction. To cope with these problems, Specialized
Emergency Nurses (SENs), regular ED-nurses receiving a short, injury-specific course, were trained
to assess and treat minor injuries according to a specific protocol.
Methods: An economic evaluation was conducted alongside a randomized controlled trial
comparing House Officers (HOs) and SENs in their assessment of ankle and foot injuries. Cost
prices were established for all parts of healthcare utilization involved. Total costs of health care
utilization were computed per patient in both groups. Cost-effectiveness was investigated by
comparing the difference in total cost between groups with the difference in sensitivity and
specificity between groups in diagnosing fractures and severe sprains. Finally, cost-effectiveness
ratios were calculated and presented on a cost-effectiveness plane.
Results: No significant differences were seen between treatment groups for any of the health care
resources assessed. However, the waiting times for both first assessment by a treatment officer
and time spent waiting between hearing the diagnosis and final treatment were significantly longer
in the HO group. There was no statistically significant difference in costs between groups. The total
costs were € 186 (SD € 623) for patients in the SEN group and € 153 (SD € 529) for patients in
the HO group. The difference in total costs was € 33 (95% CI: – € 84 to € 155). The incremental
cost-effectiveness ratio was € 27 for a reduction of one missed diagnosis and € 18 for a reduction
of one false negative.
Conclusion: Considering the benefits of the SEN-concept in terms of decreased workload for the
ED physicians, increased patient satisfaction and decreased waiting times, SENs appear to be a
useful solution to the problem of ED crowding.
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Emergency Departments (EDs) worldwide are confronted
with overcrowding due to physician shortage and a steady
growth of patients visiting the ED [1,2]. Long waiting
times in the ED lead to unsatisfied patients. Moreover,
crowding causes late diagnoses with the possibility of
unnecessary complications. To cope with these problems,
Advanced Nurse Practitioners (ANPs) and Physician
Assistants (PAs) were introduced to take over certain diag-
nostic tasks from doctors to alleviate the physicians of
some of the workload in the ED [3]. These so-called
midlevel practitioners have proven to be of good value in
the everyday practice of the ED by treating certain injuries
and conditions while maintaining a good standard of care
and patient satisfaction [4-6].
However, there are also some disadvantages to the devel-
opment: training is relatively long and expensive and
trainees are withdrawn from the already tight nurses pool
[7,8]. To resolve these disadvantages and maintain the
benefits of these practitioners, we conceived a new con-
cept: the Specialized Emergency Nurse (SEN). Regular
emergency nurses received an injury-specific course to
assess and treat minor injuries themselves according to a
protocol. SENs are trained to be flexible employees capa-
ble of treating common injuries alongside their regular
nursing duties.
The first injury to test this method on was the ankle
sprain, because it is a common injury for which validated
clinical decision rules exist that could easily be imple-
mented in an algorithm (Ottawa Ankle and Foot Rules)
[9-13].
Before this study, the ability of SENs to clinically assess
ankle and foot injuries was compared with junior emer-
gency physicians (house officers [HOs]) in an interob-
server agreement study [14]. Furthermore, the accuracy of
SENs in interpreting the accompanying radiographs was
studied [15]. The results of both studies were promising to
such a degree that a randomized controlled trial, the SEN-
trial, was set up to assess the ability and consequences of
SENs diagnosing and treating patients with an ankle or
foot injury compared with HOs. Outcome measures con-
sidered in the trial were accuracy of assessment, patient
satisfaction, and waiting time. The clinical part of the
study revealed comparable accuracy results between the
SENs and HOs. The SEN group scored significantly better
than the HO group on patient satisfaction and waiting
times. These results are presented in a separate paper [16].
At present, no literature is available about the cost-effec-
tiveness of deploying regular nurses to perform diagnostic
and treatment tasks after a short, injury-specific course.
ANPs and PAs, however, have been proven to be more
expensive than HOs [17]. The results of the economic
evaluation that was performed alongside the SEN trial are
presented in the current paper.
Methods
Study design
An economic evaluation was conducted alongside a pro-
spective randomized controlled trial (SEN-trial) compar-
ing House Officers (HOs) and Specialized Emergency
Nurses (SENs) in their assessment of ankle and foot inju-
ries in the ED. Assessment was performed by both groups
according to a protocol based on the Ottawa Ankle and
Foot rules. Effectiveness and cost-effectiveness were inves-
tigated. The protocol was approved by the scientific com-
mittee and medical ethics committee of the VU University
Medical Center and was carried out in accordance with the
Declaration of Helsinki (1989) of the World Medical
Association.
Observer groups
Out of 32 certified emergency nurses, 16 volunteered to
participate in this trial. The mean age of the nurses was 36
years (range, 26–56 years). The mean clinical experience
in the ED for the nurses was 5 years (range, 6 months–12
years).
Before the study started, the nurses were trained in the
anatomy and biomechanics (trauma mechanisms) of the
ankle and foot, and were taught how to interpret the
accompanying radiographs for the detection of acute frac-
tures in a 2-day course, provided by a surgeon and a radi-
ologist. Successful completion of the course led to the SEN
qualification. Furthermore, all HOs, 24 in total, partici-
pated in the study. The HOs' mean age was 28 years
(range, 26–30 years) and their mean clinical experience
(in an ED) was 1 year (range, 6 months–1.5 years).
Study population
Patients were randomly assigned to 1 of the 2 treatment
groups by computer, which allocated patients unstratified
into the 2 observer groups in blocks of 20. All consecutive
patients who came to the ED with an ankle or foot injury
were invited to enter the study. Exclusion criteria were: age
younger than 18 years or older than 65 years; trauma sus-
tained more than 48 hours before presentation; mental or
physical conditions known to complicate assessment of
the injury; ankle/foot injuries as part of a more severe
(poly)trauma; and prior injury to the ipsilateral ankle/
foot that required surgery. Written informed consent was
obtained from all patients. For more details on the trial,
we refer to the clinical paper [16].
Clinical outcome measures
The included patients visited the outpatient clinic again
after one week. One surgeon reassessed all patients toPage 2 of 8
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mary outcome measures were the accuracy parameters cal-
culated as the sensitivity and specificity of both observer
groups. These parameters were found by comparing the
results of both observer groups to the gold standard (sur-
geon that reviewed the radiographs and reassessed ankle
stability). The secondary outcome measure was patient
satisfaction. The clinical outcome measures and their
assessment are extensively described in the clinical paper
[16].
Assessment of resource utilization
Data regarding costs directly related to the treatment of
ankle and foot injuries were collected for each patient in
the trial. The following data were taken into account:
number of X-rays performed; use of crutches and duration
of use; initial treatment (cast, pressure bandage or
tubigrip); admittance to the hospital and duration of hos-
pitalization; operation together with the used materials
and duration of operation. Most cost parameters were col-
lected at initial presentation at the ED. Few cost parame-
ters (crutch use and hospitalization elsewhere) were
collected at the control visit or by phone (for patients who
did not return for the control visit). Data on crutch use
were collected for the last 115 patients of the study. These
data were used to estimate group means that were conse-
quently imputed for the entire group. Other costs within
the health care sector consisted of those associated with
setting up the 2-day training course as well as providing it.
Furthermore, the costs associated with the time SENs and
HOs spent on patients in both groups were included. This
was done by prospectively measuring the time spent on
clinically assessing the patient as well as the time spent on
interpreting the accompanying radiograph (if made). For
practical reasons, these data were collected for a selection
of patients and imputed for both groups.
The time loss patients experienced during the ED visit
(indirect cost of productivity loss) was also taken into
account. Data were prospectively collected concerning the
time spent in the waiting room of the ED; time between
clinical assessment and radiograph (if made), and time
spent waiting between hearing the diagnosis and final
treatment. The time spent in the waiting room was col-
lected for all patients. The waiting time between clinical
assessment and radiograph, and time spent waiting
between hearing the diagnosis and final treatment in the
ED were, because of practical reasons, collected in a ran-
dom selection of patients (n = 18). The mean of these data
were consequently imputed per group for the rest of the
study population (Table 1).
Valuation of health care consumption; unit costs
The economic evaluation was conducted from a societal
perspective. The study was carried out from August 2004
to March 2005. Therefore, 2004 prices were used. For the
most relevant cost items, cost prices for the VU University
Medical Center were calculated. These cost prices reflect
costs of real resource use and include overhead costs.
Items with a negligible influence (because of low average
numbers) were valued according to the Handbook for
economic evaluation in the Netherlands [18]. Table 2
shows the unit cost prices that were used. Waiting time
was valued using shadow prices that value time spent at
unpaid work or informal care. This shadow price equals
the tariff for hiring someone, which was € 8.30 an hour.
Statistical analysis
Statistical analysis was carried out according to the inten-
tion-to-treat principle. A total of 512 patients were
included in the trial: 263 were randomized to the SEN
group and 249 to the HO group. The total costs were com-
puted by multiplying resource data by cost prices. The dif-
ference between total costs in the SEN group and the HO
group were consequently computed and the 95% confi-
dence interval (95% CI) for this difference was calculated.
As cost data are typically skewed, confidence intervals for
cost differences cannot be estimated with conventional
methods that assume normality. To avoid distributional
assumptions, we applied the non-parametric bootstrap
[19,20]. Basically, in the non-parametric bootstrap, sam-
ples of the same size as the original dataset are drawn by
sampling with replacement from the observed data. These
bootstrap samples can be used to estimate standard errors
and confidence intervals. To obtain 95% confidence inter-
Table 1: Mean (SD) invested time spans per treatment group
SEN HO
mean (SD) N mean (SD) N
Invested time per observer (SEN/HO)
Duration clinical assessment (min) 5 (1.3) 11 5 (2.2) 7
Duration radiograph interpretation (min) 2 (0.8) 10 1.8 (1.1) 5
Duration review radiograph (min) 0.5 --- 3 0.5 --- 3
Invested time per patient
Waiting time 1st assessment – radiograph (min) 37 (12) 10 33 (8) 5
Waiting time diagnosis – treatment (min) 3 (4) 11 16 (14) 7Page 3 of 8
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bootstrap with a 1000 replications [21].
For the cost-effectiveness analysis, the difference in total
cost between the two treatment groups was compared
with the difference in sensitivity and specificity. In other
words, the increase (or decrease) in total costs per missed
diagnosis (false positives and negatives) for the SEN
group versus the HO group was calculated and constitutes
the cost-effectiveness ratio.
Uncertainty around the cost-effectiveness ratios was esti-
mated using the bias corrected and accelerated bootstrap-
ping method (1000 replications) and presented on a cost-
effectiveness plane [21,22].
Results
Clinical outcomes
SENs are capable of assessing and treating patients with an
ankle or foot trauma at least as accurate as HOs. The per-
centage of false positives and false negatives in the SEN
group was 7.4% compared with 8.6% in the HO group.
For false negatives alone, these percentages were 2.9% and
4.7%, respectively. These differences were not statistically
significant. Moreover, SENs accomplished these results
with better patient satisfaction results than did the HOs.
Furthermore, waiting times were decreased for patients
with this type of injury. Full details on the clinical out-
comes are presented in a separate paper [16].
Resource use
Table 1 summarizes the time measurements. No signifi-
cant differences were found between treatment groups
with regard to the invested time of either SEN or HO. Also,
as expected, the waiting time for patients between clinical
assessment and radiograph (if made) were not different
between groups. This waiting period depends on the pres-
sure of activities at the radiology department and is in no
way associated with the observer group. Finally, the time
spent in the waiting room of the ED and the time spent
between hearing the diagnosis and receiving final treat-
ment (eg, application of pressure bandage) was signifi-
cantly longer in the HO group.
Table 3 lists the mean utilization of health care resources
for both treatment groups. No significant differences were
seen between the two treatment groups for any of the
health care resources measured (X-ray indication; use of
crutches and duration of use; treatment modality (cast,
pressure bandage or tubigrip); hospital admittance/dura-
tion of hospitalization; and duration of operation. How-
Table 3: Mean (SD) healthcare utilisation per treatment group
SEN
(n = 261)
HO
(n = 249)
mean (SD) N* mean (SD) N*
Health care Resource
Radiograph 83% (38%) 76% (43%)
Crutch-use 67% (47%) 45 67% (47%) 70
Duration of Crutch-use (days) 9.2 (8.2) 21 8.2 (5.0) 28
Tubigrip 32% (47%) 36% (48%)
Pressure bandage 38% (49%) 41% (49%)
Lower extremity cast 22% (42%) 19% (40%)
Number of hospital admittances 3% (17%) 2% (15%)
Duration of hospitalization (days) 3.3 (2.9) 7 2.8 (1.5) 5
Duration of operation (min) 83 (35) 7 95 (22) 5
Invested time patient
Time spent in waiting room (min) 27 (23) 200 41 (35) 231
* Number of patients if different from heading.
Table 2: Costs per unit health care resource used in the 
economic evaluation of SEN (year 2004)
Healthcare resource [Unit] Cost per unit (€)
Radiograph 42
Crutch-rent per week 4
Tubigrip 7
Pressure bandage 24
Lower extremity cast 68
Hospitalization per day 482
Operating room per hour 1274
Osteosynthesis materials (mean) 270
Hourly fee SEN 30
Hourly fee HO 33
Hourly fee specialist 148
Waiting time patient 8.40*
Training SEN (per SEN) 170
* Shadowprice per hour.Page 4 of 8
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officer was significantly longer in the HO group.
Costs
Table 4 shows the mean (standard deviation) costs for the
two treatment groups. Direct health care costs were not
significantly different between the two groups. These
included the costs associated with educating the SENs.
Costs outside the health care sector were also not signifi-
cantly different between groups. As such, the total direct
costs were similar in both treatment groups. A substantial
part of the direct health care costs was attributable to hos-
pitalization and operation. Note that the indication for
hospitalization and operation is set by a supervising sur-
geon and is, therefore, independent of the treatment
group. Furthermore, the mean time spent in the waiting
room was significantly shorter in the SEN group com-
pared with the HO group. However, in absolute values,
these costs were very small in comparison to the total
costs. The total costs were € 186 (SD € 623) per patient in
the SEN group and € 153 (SD € 529) per patient in the
HO group. The difference in total costs was € 33 (95% CI:
– € 84 to € 155). This difference could be explained by the
difference in hospital admittance/operation and training
costs for the SENs, and was not statistically significant.
Cost-effectiveness
Table 5 shows the total costs and effects. Table 6 displays
the differences in total costs and the differences in effect
together with the incremental cost-effectiveness ratios.
The effect differences were 1.2% for the false negatives and
positives combined and 1.8% for the false negatives
alone. Considering the cost-difference between treatment
groups of € 33, the incremental cost-effectiveness ratio for
reduction of false negatives and positives was € 27 and the
incremental cost-effectiveness ratio for reduction of false
negatives alone was € 18. In other words, SEN cost an
additional € 27 per false positive or negative that is
avoided. Furthermore, SEN cost an additional € 18 per
false negative (missed fracture/total collateral ligament
rupture) that is avoided.
Figure 1 shows the cost-effectiveness plane for true posi-
tives gained. 65 percent of the cost-effect pairs lie above
the x-axis, the area where SEN deployment is associated
with higher costs. Furthermore, 85 percent of cost-effect
Table 4: Mean (SD) costs for treatment group for all patients
SEN
(n = 262)
HO
(n = 249)
Difference (95% CI)†
mean (SD) mean (SD)
HEALTH CARE SECTOR
Resource use
Radiograph 34.5 (15.7) 31.8 (17.8) 2.7 (-0.3 ; 5.9)
Crutch-use 4.7 (5.8) 4.4 (4.2) 0.3 (-0.5 ; 1.2)
Tubigrip 2.3 (3.3) 2.5 (3.4) -0.3 (-0.9; 0.4)
Pressure bandage 9.4 (26.6) 10.0 (26.9) -0.6 (-3 ; 2)
Lower extremity cast 15.2 (28.5) 13.2 (27.1) 2.0 (-2.3; 6.3)
Costs related to operation
Hospitalization 42.3 (333) 27.1 (210) 15.2 (-33; 65)
OR/osteosynthesis materials 52.9 (342) 46.9 (333) 6.0 (-69 ; 81)
Valuation of time of SEN or HO
Clinical assessment 2.5 --- 2.8 --- -0.2 *
Radiographic assessment 0.8 --- 0.8 --- 0.1 *
Review radiograph 2.5 --- 2.3 --- 0.2 *
Training SEN 10.4 --- 0 --- 10.4 *
INDIRECT HEALTH CARE COSTS
Time spent in waiting room 3.8 (3.3) 5.7 (4.7) -1.9 (-2.6 ; -1,2)
Waiting time assessment – radiograph 4.0 --- 3.7 --- 0.3 *
Waiting time diagnosis – treatment 0.4 --- 2.2 --- -1.8*
Total health care costs 178 (622) 142 (529) 36 (-50 ; 123)
Total indirect health care costs 8 (4) 12 (5) -3 (-4 ; -2)
Total costs 186 (623) 153 (529) 33 (-84 ; 155)
† CI estimated with a non-parametric bootstrap with 1000 replications
* CI not available; estimate at group levelPage 5 of 8
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ment is associated with more effect. Note that the differ-
ences are small and the spreading is close to zero.
Discussion
Differences in total costs between the SEN group and HO
group were not statistically significant. In daily practice,
this means that we seem to have found an attainable solu-
tion to ED crowding that reduces waiting times, increases
patient satisfaction and reduces workload for emergency
physicians without increasing the costs. SEN cost only €
27 per false positive or negative that is avoided. The small
difference in total costs in favour of the HO group is
largely attributable to the slight (non-significant) differ-
ence in number of hospital admittances/operations, that
accounts for larger costs in the SEN group. These costs are
random since hospital admittance/operation is not a deci-
sion made by the observer, though is made by a supervis-
ing surgeon. Furthermore, the cost difference could partly
be attributed to the costs of educating SENs. These costs
are overestimated, since most of these costs were made for
developing the educational programme and are not
needed when a second group of nurses is trained. In addi-
tion, once a nurse has received training, the more patients
he or she treats, the lower are the additional costs per
patient.
Only few earlier publications on the costs and cost-effec-
tiveness of alternative solutions to the problem of ED
crowding are available. In the case of ANPs/PAs, one
important publication revealed that ANP/PA delivered
care was associated with higher costs than the standard
care provided [17]. In light of these findings by Sakr et al.,
it seems that the SEN concept might constitute an attrac-
tive alternative to the currently available midlevel practi-
tioners. SENs provide the benefits of deploying nurses to
do a physicians' job as do ANPs/PAs: shorter waiting peri-
ods, decreased workload for emergency physicians and
increased patient satisfaction while maintaining excellent
diagnostic accuracy [16]. However, the costs associated
with deploying SENs seem to be lower than those associ-
ated with the deployment of ANPs/PAs. The latter are
more expensive because of the higher wages and costly
educational programmes involved. Furthermore, it is
important to note that the same results would have been
seen when HOs/Emergency Physicians would be more
expensive. This is due to the fact that the costs associated
with income of the observer constitute only a small part
of the total costs and therefore are irrelevant to the overall
costs and consequently the cost difference.
Strengths and limitations of the study
For a critical appraisal of the design of the study, we refer
to the clinical paper [16]. With respect to the collection of
information on utilization of some resources and (wait-
ing/assessment) times, some limitations should be men-
tioned. Most resources were collected for all patients.
However, as for crutch use, these data were collected for
the last 115 patients and imputed for the rest of the
groups. With regard to invested times by patients, the
overall time spent in the ED as well as time spent in the
waiting room were collected for all patients. However,
waiting times between hearing the diagnosis and final
treatment were collected for a limited number (N = 18) of
patients per group and then imputed for both observer
groups. As for the invested assessment times by the
observers, these times were all recorded in a limited
number of patients (N = 18) and then imputed for both
observer groups. When imputing the mean values from
the mentioned data, the variance was ignored. Obviously,
it would have been better if we had collected these data for
all patients. However, the sensitivity analysis performed
later, resulted in similar results and therefore, the method
used seems justified. Furthermore, since the effect is an
underestimation of the variance, an increase in the vari-
ance will only affirm the observation that cost differences
between the groups are not significant and therefore will
not influence the conclusions drawn.
For the remaining resource variables, very few data were
missing and considering the large sample size, estimates
are considered to be accurate. With over 500 patients
Table 6: Mean cost and effect differences between treatment groups and cost-effectiveness ratios for all patients (missing data 
imputed)
SEN- HO
Effect measure Cost difference† Effect difference† Incremental Cost-effectiveness ratio
Decrease in false positives and false negatives 33 1.2 % 27
Decrease in false negatives 33 1.8 % 18
Table 5: Mean costs and effects by treatment group for all 
patients (missing data imputed)
SEN (n = 242) HO (n = 233)
Effect measure Costs Effects Costs Effects
False positives and false negatives 186 7.4 % 153 8.6 %
False negatives 186 2.9 % 153 4.7 %Page 6 of 8
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were collected prospectively, contributing to the strength
with which conclusions can be drawn from the presented
results.
Conclusion
Considering the results of this study and keeping in mind
the results of the accompanying clinical trial, costs and
effects are equal for both the SEN group and the HO
group. SENs cost only € 27 per false positive or negative
and only € 18 per false negative that is avoided. Consid-
ering the benefits of the SEN-concept in terms of
decreased workload for the physicians working in the ED,
the increased patient satisfaction and shorter waiting
times in the SEN group, SENs appear to be an attractive
solution to the problem of ED crowding.
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